Global Market To Dominate The Actinic Keratosis Treatment Market

Posted by Merin John on May 11th, 2021

Increasing awareness about the adverse impacts of actinic keratosis and its association with the development of non-melanoma cancer coupled with the growing prevalence of the condition around the world is estimated to fuel the market growth which is expected to witness robust growth during the 2018-2028 period, according to a recent study by Persistence Market Research.

Actinic keratosis is estimated to affect 10% of the female population in the US while over 26% of the total male population in the country develops the condition. In Britain, actinic keratosis affects an estimated 15% of the male population and can 6% of the female population.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/27691

Company Profile:

Sun Pharmaceutical Industries Ltd.

Biofrontera

Nestle SA

Bausch Health Companies Inc.

Novartis AG

GlaxoSmithKline plc.

Almirall, LLC

LEO Pharma Inc.

Cipher Pharmaceuticals Inc

Pierre Fabre Pharmaceuticals, Inc.

BioLineRX

Alma Lasers

Valeant Pharmaceuticals

3MStanford Chemicals.

The burgeoning prevalence of actinic keratosis in the global population is expected to fuel demand for effective treatment options.

The abundance of clinical data for actinic keratosis treatment is estimated to aid in the development of novel medications and therapies. The vast amount of clinical data available is being leveraged to understand and develop new and innovative options for effective treatment of actinic keratosis in different patients.

Availability of data is also enabling dermatologists and surgeons to develop customized combination therapies for patients. These factors are estimated to provide a conducive platform for the development of novel treatment options and are expected to contribute significantly to the actinic keratosis market revenue.

Low cost of topical medication and higher success rates for treatment of mild to moderate cases of actinic keratosis is causing a widespread adoption of the method as the first line of treatment. Additionally, the convenience of self-prescribing gels and creams used in the topical treatment and their availability at retail and pharmaceutical stores are vital factors which are causing a surge in the demand for topical medications among patients.

Due to these factors, topical treatment is expected to hold the bulk of the actinic keratosis market share at the end of the forecast period.

Like it? Share it!


Merin John

About the Author

Merin John
Joined: December 11th, 2020
Articles Posted: 262

More by this author